0001638599-20-000912.txt : 20201123
0001638599-20-000912.hdr.sgml : 20201123
20201123160528
ACCESSION NUMBER: 0001638599-20-000912
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201119
FILED AS OF DATE: 20201123
DATE AS OF CHANGE: 20201123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GANDOLFO JOHN P
CENTRAL INDEX KEY: 0001200155
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38365
FILM NUMBER: 201337263
MAIL ADDRESS:
STREET 1: 62 TERRACE ROAD
CITY: WAYNE
STATE: NJ
ZIP: 07470
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYENOVIA, INC.
CENTRAL INDEX KEY: 0001682639
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471178401
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 295 MADISON AVENUE,
STREET 2: SUITE 2400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 813-766-9539
MAIL ADDRESS:
STREET 1: 295 MADISON AVENUE,
STREET 2: SUITE 2400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4_6927.xml
PRIMARY DOCUMENT
X0306
4
2020-11-19
0
0001682639
EYENOVIA, INC.
EYEN
0001200155
GANDOLFO JOHN P
C/O EYENOVIA, INC.
295 MADISON AVENUE, SUITE 2400
NEW YORK
NY
10017
0
1
0
0
Chief Financial Officer
Common Stock, par value $.0001
2020-11-19
4
P
0
4000
3.40
A
6000
D
Stock Option (right to buy)
2.72
2030-06-02
Common Stock
114774
114774
D
Stock Option (right to buy)
8.72
2028-04-16
Common Stock
71200
71200
D
Stock Option (right to buy)
6.20
2028-07-24
Common Stock
24842
24842
D
Stock Option (right to buy)
3.11
2029-08-16
Common Stock
53402
53402
D
One-third of the option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
The option became exercisable as to 1,977 shares on May 16, 2018 and becomes exercisable in equal 1,977 share amounts on each of the 35 one-month anniversaries thereafter.
One-third of the option became exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
One-third of the option became exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
/s/ S. Halle Vakani, Attorney-in-Fact
2020-11-23